New Type of Cancer Immunotherapeutic Approved by FDA: What It Means for Leukemia Patients

Earlier this month we witnessed another leap forward for immunotherapy when the FDA approved blinatumomab (Blincyto) for the treatment of certain patients with acute lymphoblastic leukemia (ALL).

Read More